Encontrados 4 documentos, a visualizar página 1 de 1

Ordenado por Data

Inherited and acquired risk factors and their combined effects in pediatric stroke

Barreirinho, Maria Sameiro; Ferro, Anabela; Santos, Manuela; Costa, Elísio; Pinto-Bastos, Jorge; Sousa, Alda; Sequeiros, Jorge; Maciel, Patricia

The aim of this study was to identify hereditary and acquired risk-factors as they are related to the occurrence of stroke in children. We identified 21 children with stroke. A search of the Factor V Leiden mutation, the Factor II G20210A variant, and the thermolabile variant of methylenetetrahydrofolate reductase was performed in patients and in a control group (n = 115).We identified risk factors of acquired ...

Data: 2003   |   Origem: Biblioteca Digital do IPB

Ten years of prophylactic treatment with fresh-frozen plasma in a child with ch...

Barbot, José; Costa, Elísio; Guerra, Marisol; Barreirinho, Maria Sameiro; Isvarlal, Pratima; Robles, Rodolfo; Gerritsen, Helena; Lammle, Bernhard

We report the results of 10 years of prophylactic fresh-frozen plasma (FFP) infusion therapy in a 14-year-old girl with chronic relapsing thrombotic thrombocytopenic purpura (TTP), in whom a severe congenital von Willebrand factor (VWF)-cleaving protease deficiency has been documented. Severe haemolytic crises triggered by infections were prevented and her present renal and neurological functions have been pres...

Data: 2001   |   Origem: Biblioteca Digital do IPB

Prothrombotic study in full term neonates with arterial stroke

Carrilho, Inês; Costa, Elísio; Barreirinho, Maria Sameiro; Santos, Manuela; Barbot, Clara; Barbot, José

Data: 2001   |   Origem: Biblioteca Digital do IPB

Brain stem ischemia in a boy with resistance to C activated protein and raised ...

Barreirinho, Maria Sameiro; Costa, Elísio; Moreira, Ana; Barbot, José; Barbot, Clara; Santos, Manuela

La resistencia a la proteína C activada es la alteración hereditaria de la coagulación más frecuente. La mayoría de los casos resulta de la mutación Arg506®Gln en el gen del factor V, y se caracteriza por una respuesta reducida a la acción anticoagulante de la proteína C activada. Caso clínico. Descibimos el caso de un niño de 6 años, obeso, con hemiparesia derecha de instalación súbita por infarto en la hemipr...

Data: 1999   |   Origem: Biblioteca Digital do IPB

4 Resultados

Texto Pesquisado

Refinar resultados

Autor











Data




Tipo de Documento


Recurso


Assunto















    Financiadores do RCAAP

Fundação para a Ciência e a Tecnologia Universidade do Minho   Governo Português Ministério da Educação e Ciência Programa Operacional da Sociedade do Conhecimento União Europeia